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deficit induced by beta amyloid and evaluation
of mitochondrial function markers in the
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Ladan Behzadfar,a Mohammad Abdollahi,a Omid Sabzevari,a Rohollah Hosseini,a
Ahmad Salimi,b Parvaneh Naserzadeh,c Mohammad Sharifzadeh*a and
Jalal Pourahmad *c
Mounting evidence suggests that copper, a crucial element in normal brain function, plays an important
role in the etiology of Alzheimer’s disease, which is known as a neurodegenerative mitochondrial
disorder. However, the precise mechanisms of its eﬀects on cognitive and mitochondrial functions
through the CNS have not been thoroughly recognized yet. In this study, we aimed to investigate the
long-term (3-week) eﬀects of copper sulfate (50, 100 and 200 mg kg1 day1) exposure on learning and
memory as well as on mitochondrial function in the hippocampus of rats in the presence and absence
of beta amyloid (1 mg ml1 per side) intrahippocampally (IH). After three weeks of copper exposure
through drinking water, acquisition and retention of spatial memory were measured by the Morris water
maze (MWM) test. Various parameters of mitochondrial function were also evaluated. Our data show
that copper damaged the spatial learning and memory and also exacerbated the memory deficit
induced by Ab injection in rats in a dose-dependent manner. Mitochondria isolated from the
hippocampus of rats treated with copper showed significant increases in ROS formation, mitochondrial
swelling, lipid peroxidation, glutathione oxidation, outer membrane damage, and collapse of MMP,
decreased cytochrome c oxidase activity, and finally increased ADP/ATP ratios. Our results indicate that
copper overloading in the hippocampus of rats causes mitochondrial dysfunction and subsequent
oxidative stress leading to cognitive impairment. This study also reveals that copper can potentiate Ab
deleterious eﬀects on spatial memory and brain mitochondrial function.
1. Introduction
Copper (Cu2+), an essential trace element, is an integral part of
many important enzymes required for many vital biological
processes such as energy production, scavenging of free radicals,
iron mobilization, neurotransmission and catalytic functions in
living cells and their organelles, particularly mitochondria.1 Of all
the metals causing pollution, copper is a common pollutant in
aquatic environments, especially those which are surrounded
by populating areas with increased discharge through various
industrial and domestic eﬄuents.2 Therefore, Cu2+ toxicity has
been linked to chronic Cu2+ overload and/or exposure to excess
copper caused by accidents, occupational hazards, environ-
mental contamination or inborn copper metabolic disorders.1,3
Besides that, a relatively high level of this redox active metal can
be toxic and can mediate the formation of reactive oxygen species
(ROS) in aerobic cells.4,5 Homeostatic alterations in cerebral
copper levels have also been implicated in the pathogenesis of
Alzheimer’s disease (AD) and possibly other neurodegenerative
disorders such as Parkinson’s and Prion diseases.6,7
Alzheimer’s disease (AD) is an epidemic type of dementia in
the U.S. and other developed countries. It has been evaluated
that 10% of people in their 60s, 20% in their 70s, and 30% in
their 80s have AD in the U.S.8,9 Gradually, our population is
growing older, so we have more AD, a disease of aging. Some
hypothesize that the epidemics of AD in populations over the
age of 50 are mainly due to inorganic copper ingestion in
drinking water and copper supplements.10
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Amyloid beta (Ab), the main component of senile plaques in
Alzheimer’s disease is generated from amyloid precursor protein
(APP) cleavage by beta-site APP-cleaving enzyme 1 (BACE1).11,12
Accumulating evidence suggests that Cu2+ can promote Ab
aggregation and reduce Ab degradation in a dose-dependent
manner.13 The mRNA and protein expression levels of APP and
BACE1, which play an important role in Ab generation, were
increased in cells exposed to Cu2+.11,14,15 Some studies suggest
that the NEP, a protease that degrades Ab expression levels in
mRNA and protein was also decreased in cells treated with
Cu2+.16,17 Two main receptors, the low-density lipoprotein
receptor-related protein 1 (LRP1) and advanced glycation end
products (RAGE) on the BBB, play an important role in control-
ling Ab levels in ISF. LRP1 is a primary transporter of Ab across
the BBB out of the brain, while RAGE is a main transporter
protein for Ab influx in ISF.18,19 Brain endothelial mRNA
expression of LRP1 was found to be lower in the brain tissue
from AD patients than controls, leading to Ab accumulation in
the ISF.20–23 Some have suggested that Cu2+ in drinking water
leads to a decrease of Ab clearance in the brain.23,24
There are two pools of copper in the blood, one which is
‘‘safe’’ copper, covalently bound to ceruloplasmin (cp), and the
other, called ‘‘free’’ copper, loosely bound to albumin and other
small molecules in the blood.25 The free copper, which makes
up about 5–15% of the total serum copper is the potentially toxic
form. For example, in Wilson’s disease, an inherited disease of
copper accumulation, the free copper pool is greatly expanded.26
It turns out, as reported by Squitti’s group in Italy, that there
are elevated free copper levels in AD patients and they have also
shown that free copper levels negatively correlate with cognition
in AD patients.25,27
Animal model studies have provided a powerful piece of
evidence linking AD disease to copper toxicity. Sparks et al.23
observed that adding just 0.12 ppm (0.75 mM) copper (one-tenth
of the environmental protection agency human consumption
limits) to drinking water was suﬃcient to precipitate the
accumulation of Ab in the brains of cholesterol-fed rabbits.
Subsequent studies indicated that adding Cu2+ to the drinking
water of Cholesterol-fed rabbits produced an 80% deficit in
their ability to acquire complex memory and learning compared
to those who were fed the same diet without adding copper in
the drinking water.23
Previous studies reported that Cu2+ with high aﬃnity binds
soluble monomeric Ab via binding sites in the N-terminus, and
coordinates with Ab in a planar configuration with histidines
(His6, His13, and His14)28,29 and Tyr10.30 Actually, Cu–Ab
interactions can increase free radical generation and neuro-
toxicity. When Ab binds free ionic copper in the presence of
appropriate reductants such as cholesterol, ascorbic acid or
dopamine, the Ab–Cu(II) complex can continue to generate
significant quantities of ROS by catalyzing the reduction of
Cu2+ to Cu1+.28,31
During the energy production in mitochondria, ROS is
produced as a byproduct of oxidative phosphorylation. Thus,
the mitochondrion is supposed to be one of the important
sources of ROS production.32,33 Increased ROS production caused
mitochondrial and cellular dysfunction. A negative correlation
has been found between oxidative stress, mitochondrial dys-
function and impairments in behavioral tests.34 Recent studies
have shown that copper administration caused a reduction in
the activities of mitochondrial enzymes and induction of the
mitochondrial permeability transition (MPT). The MPT is deter-
mined by the opening of the permeability transition pore (PTP),
which is located in the inner mitochondrial membrane (IMM).
This increased permeability of IMM led to a dissipation of the
mitochondrial membrane potential and reduced ATP production
in the rat brain.35,36 It has been suggested that mitochondrial
respiration plays a vital role in the plasticity needed for spatial
learning and memory.37 It can be hypothesized that copper
results in spatial learning and memory impairments through
induction of mitochondrial dysfunction in the hippocampus.
However, this hypothesis needs direct confirmation because far
too little consideration has been paid to the mechanistic relation
between mitochondrial dysfunction and learning and memory
impairments caused by copper alone and in combination with Ab.
Based on these reports and observations, we aimed to evaluate
the eﬀects of diﬀerent doses of copper sulfate in drinking water
in the presence and absence of Ab on spatial memory retention in
adult male rats using the Morris Water Maze (MWM) task. We
also investigated the possible mitochondrial mechanisms
mediating the eﬀects of copper ion solely and with Ab on spatial
learning and memory in isolated brain hippocampi of rats.
2. Materials and methods
2.1. Materials
CuSo4 was purchased fromMerck (Darmstadt, Germany). Amyloid
beta (1–42), 4-2-hydroxyethyl-1-piperazineethanesulfonic acid
(HEPES), rotenone (Rot), dimethyl sulfoxide (DMSO), D-mannitol,
thiobarbutiric-acid (TBA), 20,70-dichlorofluoresceindiacetate
(DCFH-DA), Tris–HCl, sodium-succinate, sucrose, KCl, Na2HPO4,
MgCl2, Rhodamine123 (Rh123), Coomassieblue, Ethylene glycol-
bis (2-aminoethylether)-N,N,N0,N0-tetraacetic acid(EGTA), xylazine
and Ketamine were purchased from Sigma Chemical Co. (St. Louis,
MO, USA). All chemicals used for this experiment were of the best
analytical and pharmaceutical grade available.
2.2. Animals
Male rats of the Albino-Wistar strain weighing 220–250 g were
obtained from the Faculty of Pharmacy, Tehran University of
Medical Sciences. All animal groups were housed in cages until
surgery and handled daily with free access to food and water.
The light/dark cycle was maintained at 12 h/12 h and temperature
and humidity were controlled. All animal manipulations were
approved by the Tehran University of Medical Sciences Animal
Ethics Committee. Efforts were made to reduce the number of
animals used and to minimize animal suffering.
2.3. Preparation of beta-amyloid peptide 1–42 (Ab 1–42)
The Amyloid beta 1–42 was dissolved in phosphate buffer saline
(PBS 0.1 M) with a concentration of 200 mg ml1 and incubated
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for 5 days at 37 1C. Aliquots of Amyloid beta were stored at
20 1C until they were used. On the test day, they were diluted
to reach a final concentration of 1 mg ml1.
2.4. Stereotaxic surgery
Rat anesthetization was performed by intra-peritoneal injection
of 100mg kg1 Ketamine hydrochloride combined with 20mg kg1
xylazine before placement in a stereotaxic device (Stoelting, USA). An
incision was made along the midline. The surgical area was cleaned
and in order to decrease bleeding, a drop of dental hemostop was
employed. Intrahippocampal injections of amyloid beta at the CA1
site were made 3 mm posterior and 2.1 mm lateral to bregma and
2.2 mm ventral to the surface of the skull, according to Paxinos and
Watson’s atlas (Paxinos and Watson, 2006). Amyloid beta or vehicle
(1 ml per site) was infused bilaterally into the CA1 area (0.5 ml min1).
All microinjections were performed with a 10 ml Hamilton syringe
and the needle was left in the tissue for 1 min after each injection.
2.5. Experimental design
In the present study, the animals were divided into the following
groups (n = 7 for each group): (i) a vehicle group, which received
bilateral intra-CA1 administration of PBS (the vehicle for Ab)
(1 ml per side); (ii) an Ab-injected group, which received Ab
(1 mg ml1 per side) bilateral intra-CA1; (iii) a control group,
which only received tap water; (iv) copper groups, which
received 50, 100 and 200 mg kg1 Cu2+ daily in the drinking
water for 21 days; (v) combination groups, which first received
bilateral intra-hippocampal infusions of Ab (1 mg ml1 per side) and
then received copper (50, 100 and 200mg kg1 daily in the drinking
water for 21 days); and (vi) a positive control group for behavioral
tests, which received 1 mg per side nicotine intrahippocampally. The
aforementioned groups entered two experimental protocols:
behavioral experiments and mitochondrial studies.
2.6. Spatial learning and memory assessment
The spatial memory of all the experimental groups was evaluated
by the Morris water maze (MWM) test. This maze included a
black circular pool with a diameter of about 136 cm and a depth
of 35 cm. The pool was filled with water to a depth of 40 cm (25
2 1C). This pool was divided into four equal quadrants and an
invisible platform (10 cm in diameter) was located 1 cm under
the water surface in the center of the north-west quadrant (target
quadrant). The rats were trained for 4 days such that each day
included one block consisting of four trials. In each trial, the rats
were randomly placed in one of the four quadrants. A video
camera was located just above the pool, linked to a computer and
equipped with Ethovision software (Noldus Information Technology,
Wageningen, Netherlands) that recorded the swimming pathway
and related data. Animals were allowed to swim in the pool for a
maximumof 90 seconds. If the rats did not find the hidden platform
within this period, the researcher manually guided the animal to the
platform. The rats were then rested on the platform for 20 s.
Learning capabilities were measured by quantitative computer
data in terms of escape latency (time to find the platform),
traveled distance (path length to reach the platform), and
swimming-speed. After four training days, the rats were tested
for probe trial. In the probe trial test, the platform in the target
quadrant was removed. The rats were released on the opposite
site of the target quadrant and allowed to swim for 90 seconds
freely. The time each animal spent in the target quadrant was
measured in the probe test.
2.7. Hippocampal mitochondrial function
2.7.1. Hippocampal mitochondrial isolation. After completion
of MWM, all animals were sacrificed by cervical decapitation
and the brain hippocampal tissues were obtained. Then, with
a glass handheld homogenizer, these tissues were minced
and homogenized. Mitochondria were prepared from the rats’
hippocampi by diﬀerential centrifugation.38 First, the samples
were centrifuged (at 1500g, 10 min at 4 1C) and the broken cell
debris and nuclei were sedimented. The supernatant was exposed
to centrifugation again at 10000  g for 10 min. The upper layer
was discarded and the mitochondrial pellet was washed and
suspended in the isolation medium and centrifuged again (at
10000g, 10 min). Final suspensions of mitochondrial pellets were
prepared in Tris buﬀer containing (0.05 M Tris–HCl, 0.25 M
sucrose, 2.0 mMMgCl2, 20 mM KCl and 1.0 mM Na2HPO4, pH of
7.4) at 4 1C, except for mitochondrial samples used to measure
the ROS level, mitochondrial membrane potential (MMP) and
swelling, which were incubated in respiration buffer (10 mM Tris,
0.32 mM sucrose, 20 mM Mops, 0.5 mM MgCl2, 50 mM EGTA,
5 mM sodium succinate and 0.1 mM KH2PO4), MMP assay
buffer (68 mM D-mannitol, 220 mM sucrose, 10 mM KCl, 5 mM
KH2PO4, 2 mM MgCl2, 5 mM sodium succinate, 50 mM EGTA,
10 mM HEPES and 2 mM rotenone) and swelling buffer (3 mM
HEPES, 70 mM sucrose, 230 mM mannitol, 5 mM succinate,
2 mM Tris-phosphate and 1 mM of rotenone), respectively.
Protein concentrations were measured using the Coomassie
blue protein-binding protocol as explained by Bradford.38 For
the normalization process in all the following assays, the
mitochondrial samples (0.5 mg mitochondrial protein per ml)
were used. To guarantee high quality mitochondrial preparation,
all the steps were operated on ice.
2.7.2. Measurement of the hippocampal mitochondrial
ROS levels. Measurements of the mitochondrial ROS levels
were performed by a fluorescence spectrophotometer using
DCFH-DA. Briefly, isolated mitochondria were incubated with
a respiration buﬀer39 and DCFH-DA was added (final concentration,
10 mM) to the mitochondrial samples and then incubated for
10 min. After entry, DCFH-DA was hydrolyzed to non-fluorescent
dichloro-fluorescin (DCFH), which reacted with ROS and made
highly fluorescent dichlorofluorescin (DCF). Then, the fluores-
cence intensity of DCF was quantified at time intervals of 5, 15,
30, 45 and 60 min using a Shimadzu RF5000U fluorescence
spectrophotometer device at excitation and emission wavelengths
of 500 nm and 520 nm, respectively.40
2.7.3. Measurement of the hippocampal mitochondrial
membrane potentials. For the estimation of the mitochondrial
membrane potentials (MMP), the mitochondrial uptake of a
cationic fluorescent dye, Rhodamine 123 (Rh123), was used.
Mitochondrial fractions in the MMP assay buﬀer were incubated
with 10 mM of Rh123. Then, the fluorescence was monitored at
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time intervals of 5, 15, 30, 45 and 60 min using the Shimadzu
RF5000U fluorescence spectrophotometer device at an excitation
wavelength of 490 and an emission wavelength of 535 nm.41
2.7.4. Measurement of hippocampal mitochondrial swelling.
Determination of hippocampal mitochondrial swelling was done
through changes in light scattering measured spectrophoto-
metrically at 540 nm (30 1C).42 The isolated brain mitochondria
were suspended in swelling buﬀer and the absorbance was
determined at 540 nm at time intervals of 5, 15, 30, 45 and
60 min with an ELISA reader apparatus (Tecan, Rainbow Thermo
and Austria). A reduction in absorbance was an indicator of
mitochondrial swelling.
2.7.5. Measurement of cytochrome c oxidase activity and
assessment of outer mitochondrial membrane damage. Both
mitochondrial outer membrane integrity and cytochrome c
oxidase activity were measured using a cytochrome c oxidase
assay kit (Sigma, St. Louis, MO). In the colorimetric trial, a decrease
in absorbance was caused by oxidation of ferrocytochrome c at
550 nm to ferricytochrome c by cytochrome c oxidase. Experimental
procedures were done according to the manufacturer’s protocol;
20 mg of isolated mitochondrial fraction were used for each
reaction, and duplicate reactions were performed for each assay.
For the determination of total mitochondrial cytochrome-c
oxidase activity, hippocampal mitochondrial fractions were diluted
in the enzyme dilution buﬀer (10mMTris–HCl, pH = 7.0, containing
250 mM sucrose) with 1 mM n-dodecyl b-D-maltoside and placed on
ice for 30 min. The reaction was performed by adding freshly
ferrocytochrome-c substrate solution (0.22 mM) to the sample. The
decrease in absorbance at 550 nm is linked to the oxidation of
ferrocytochrome-c by cytochrome-c oxidase. Cytochrome-c oxidase
activities were measured and normalized for the amount of protein
per reaction and the results were shown as units per milligram of
mitochondrial protein. Themitochondrial outermembrane integrity
was determined by evaluating the cytochrome-c oxidase activity
of the mitochondria in the presence or absence of n-dodecyl b-D-
maltoside as a detergent. The mitochondrial outer membrane
damage was measured through the ratio between cytochrome-c
oxidase activity with and without detergent.
2.7.6. Measurement of mitochondrial lipid peroxidation.
The MDA content was measured using the method of Zhang
et al. 2008.43 The mitochondrial fractions were incubated (1 h)
with various concentrations of uranyl acetate at 30 1C; after-
wards, 0.25 ml sulfuric acid (0.05 M) was added to 0.2 ml
mitochondrial fractions, with the addition of 0.3 ml TBA 0.2%.
All the microtubes were put in a bath of boiling water for
30 min. Finally, the tubes were placed in an ice-bath and 0.4 ml
n-butanol was added to each of them. Then, they were centri-
fuged (3500  g) for 10 min. The amount of MDA formed
in each sample was evaluated by measuring the absorbance of
the supernatant at 532 nm with an ELISA reader apparatus
(Tecan, Rainbow Thermo, Austria). Standard tetramethoxy-
propane (TEP) was used and the MDA content was represented
as mg mg1 protein.43
2.7.7. Measurement of mitochondrial GSH contents. Mito-
chondrial GSH contents were evaluated using the spectrophoto-
meter method and DTNB as the indicator for the isolated
hippocampal mitochondria. The mitochondrial fractions were
incubated with various concentrations of uranyl acetate (1 h) at
30 1C and then the mitochondrial fractions (0.1 ml) were added
into phosphate buﬀers (0.1 mol L1) and DTNB (0.04%) in a
total volume of 3.0 ml (pH 7.4). At 412 nm the yellow color was
read on a spectrophotometer (UV-1601 PC, Shimadzu, Japan).
The GSH amount was illustrated as mg mg1 protein.44
2.7.8. Determination of mitochondrial ADP/ATP ratios. To
determine the ADP/ATP ratios, the sample tissues were quickly
homogenized (4 1C) in a 1 ml of ice cold TCA (6%) and then
centrifuged at 12 000 g (10 min; at 4 1C). The supernatant was
removed and neutralized with KOH (4 M). High-performance
liquid chromatography (HPLC) was performed using a 510-
pump and a solvent delivery system (Waters Chromatography
Division, Milford, MA) and column (SUPELCOSIL1 LC-18-T,
Supelco, Inc., Bellefonte, PA) equipped with a guard column,
and finally 486 UV-Visible Detector (Waters Chromatography
Division, Milford, MA). Isocratic elution (flow: 1 ml for 20 min
at 254 nm) with tetra-butyl ammonium hydrogen sulfate
(4 mM) in potassium phosphate buﬀer (0.1 M; pH 5.5) and
methanol (85 : 15 v/v) was used according to the protocol
provided.45 The levels of ATP and ADP were measured by the
standard curve and then the ratio was evaluated.
2.8. Hippocampal copper measurements
Copper concentrations were measured in the hippocampi using
an atomic absorption spectrophotometry device (GBC Avanta
Sigma; GBC Scientific Equipment PTY Ltd, Dandenong,
Victoria, Australia). Briefly, a homogenized sample (0.5 g of
wet weight) was digested with a mixture of nitric acid and
perchloric acid (6 : 1, v/v) and the digested tissue was brought to
a constant volume with double distilled deionized water.
2.9. Statistical analysis
The results for each group are presented as mean  SD.
GraphPad Prism-6 (GraphPad Software, La Jolla, CA) was used
for the statistical analysis. A mean value for each dependent
parameter of memory performance (traveled distance, escape
latency and swimming speed) was evaluated over four trials in four
training days. Mean values for each dependent measure of mito-
chondrial function (ROS level, MMP, and mitochondrial swelling)
were also calculated over 5 time points (5, 15, 30, 45 and 60 min).
Statistical significance between the groups was determined
by one-way analysis of variance (ANOVA) using a Bonferroni post hoc
multiple comparison test and the P value was set lower than 0.05.
3. Results
3.1. Memory performance in MWM
Behavioral tests (MWM) were performed in order to evaluate
the long term eﬀects of copper exposure through the drinking
water alone and in combination with Ab (IH) on the learning
and memory function of the rats. Fig. 1 shows the traveled
distance (1A), escape latency (1B) and swimming speed (1C) for
the control, vehicle (IH) and Ab (IH) groups. Ab caused a
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significant increase in traveled distance (Po 0.001) and escape
latency (Po 0.01) compared to the control group. In contrast to
Ab, sole vehicle administration did not significantly change the
traveled distance and escape latency compared to the control
group. As shown in Fig. 1C, no significant diﬀerence was
observed between these groups in the swimming speed test.
Fig. 2 shows the results of nine groups, including the control
group, copper groups (50, 100 and 200 mg kg1 daily), Ab (IH)
injected group, combination groups that received Ab (IH) plus
copper (50, 100 and 200mg kg1 day1) and nicotine (IH) group.
Nicotine caused a significant improvement in the traveled
distance and escape latency (Po 0.01) compared to the control
group. Copper significantly increased the traveled distance
(200 mg kg1: Po 0.05) and escape latency (100 and 200 mg kg1:
P o 0.05) compared to the control group. In combination
groups also, significant increases in the traveled distance
(Cu 100 + Ab: Po 0.05; Cu 200 + Ab: Po 0.01) and escape latency
(Cu 200 + Ab: P o 0.05) compared to the group that had just
received Ab (Fig. 2A and B) were observed. It is noteworthy that no
significant diﬀerence was observed in the mean of velocity between
all nine groups on 4 training days of MWM (Fig. 2C).
The results of the probe trial test show that this parameter
significantly decreased in the Ab group (Po 0.01) compared to
the control group. Also, there was no significant diﬀerence
between the vehicle group and the control group (Fig. 3A).
Copper doses (100 and 200 mg kg1: P o 0.05) significantly
decreased the time spent in the target quadrant in the probe
trial test compared to the control group. Moreover, a significant
decrease for the Cu 200 mg kg1 plus Ab group (P o 0.05)
compared to the Ab injected group for this parameter was
observed (Fig. 3B).
Fig. 1 A plot of the eﬀect of the control, vehicle and Ab groups on the
means of traveled distance (A), escape latency (B) and swimming speed (C)
over 4 days in the MWM test. **P o 0.01 and ***P o 0.001 compared to
the control group. Values represent means  SEM of 7 animals per group.
Fig. 2 A plot of the eﬀect of copper doses, Ab, copper doses + Ab and
nicotine treatment in animals on the means of traveled distance (A), escape
latency (B) and swimming speed (C) over 4 days in the MWM test.
*P o 0.05, **P o 0.01, ***P o 0.001 and ****P o 0.0001 compared to
control group. #P o 0.05 and ##P o 0.01 compared to Ab-injected
group. Values represent means  SEM of 7 animals per group.
Metallomics Paper
Pu
bl
ish
ed
 o
n 
03
 M
ay
 2
01
7.
 D
ow
nl
oa
de
d 
by
 C
or
ne
ll 
U
ni
ve
rs
ity
 L
ib
ra
ry
 o
n 
29
/0
6/
20
17
 0
5:
52
:0
5.
 
View Article Online
Metallomics This journal is©The Royal Society of Chemistry 2017
The results of these comparisons indicate that copper in the
drinking water significantly increased the traveled distance and
escape latency on four training days of MWM (Fig. 2A and B)
and decreased the time spent in the target quadrant in the
probe trial test of MWM (Fig. 3B), which illustrates that high
doses of copper caused spatial memory impairment. Furthermore,
the results show that copper in combination with Ab could have
intensified the increase in traveled distance and escape latency on
the 4 training days of MWM (Fig. 2A and B) as well as reducing the
time spent in the target quadrant in the probe trial test (Fig. 3B).
3.2. Mitochondrial function
3.2.1. Mitochondrial ROS formation. The results of the
comparisons show that diﬀerent doses of copper (100 and
200 mg kg1: P o 0.05) induced a significant increase in ROS
generation in a concentration dependent manner, in comparison
with the control group. In addition, a more substantial increase in
mitochondrial ROS formation was observed in the Cu 200 mg kg1
plus Ab group (Po 0.05) compared to the Ab peptide treated group
(Fig. 4A).
3.2.2. Mitochondrial membrane potential. MMP is an
important indicator of the mitochondrial inner membrane
situation; therefore, the eﬀect of copper on MMP was measured
by Rh123 staining. As shown in Fig. 4B, Cu 100 mg kg1 (Po 0.05)
and 200 mg kg1 (P o 0.01) strongly decreased MMP in a
concentration-related manner, compared to the control group.
Moreover, in the combination groups, significantly reduced MMP
for the Cu 100 mg kg1 + Ab (Po 0.05) and Cu 200 mg kg1 + Ab
groups (P o 0.01) compared with the Ab treated group has been
shown (Fig. 4B).
3.2.3. Mitochondrial swelling. Mitochondrial swelling is a
determinant indicator of mitochondrial membrane permeability.
The results of comparisons show that Cu 100 mg kg1 (Po 0.05)
and 200 mg kg1 (P o 0.01) significantly caused mitochondrial
swelling in a dose-dependent manner, in comparison with the
control group (Fig. 4C). Furthermore, as illustrated in Fig. 4C,
there was significant mitochondrial swelling for Cu 100 mg kg1 +
Ab and Cu 200 mg kg1 + Ab (P o 0.05) compared to the
Ab-injected group.
Fig. 3 A plot of the eﬀect of the control, vehicle and Ab groups (A) and
copper doses, Ab, copper doses + Ab and nicotine groups (B) on time
spent in the target quadrant in the probe trial test of MWM. *P o 0.05,
**P o 0.01, ***P o 0.001 and ****P o 0.0001 compared to the control
group. #P o 0.05 compared to Ab-injected group. Values represent
means  SEM of 7 animals per group.
Fig. 4 A plot of the eﬀect of the control, copper doses, Ab and copper
doses + Ab groups on means of the ROS generation (A), MMP (B) and
swelling (C) of rat hippocampal mitochondria at 5 time points (5, 15, 30,
45 and 60 min). *Po 0.05, **Po 0.01, ***Po 0.001 and ****Po 0.0001
compared to control group. #P o 0.05 and ##P o 0.01 compared to
Ab-injected group. The values represent means  SD (n = 7).
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3.2.4. Mitochondrial cytochrome c oxidase activity and outer
membrane integrity. Cytochrome c oxidase activity (complex IV), a
main enzyme in the mitochondrial respiratory complex, was also
determined in the isolated Hippocampal mitochondria. As shown in
Fig. 5A, there was a dose-dependent relationship between cyto-
chrome c oxidase activity and Cu doses. Thus, significant collapses
in the activity of this enzyme were observed in the Cu 100 and
200 mg kg1 groups (Po 0.05) compared to the control group.
Besides, combination groups also significantly decreased the
enzyme’s activity (for Cu 50 and 100 mg kg1 plus Ab: Po 0.05;
for 200 mg kg1 plus Ab: P o 0.01) in comparison with the
Ab group (Fig. 5A). In mitochondrial outer membrane damage
assays, the cytochrome c oxidase activity was measured in the
presence/absence of the detergent, n-dodecyl b-D-maltoside. This
ratio represents the percentage of hippocampal mitochondrial
outer membrane damage. Our results show that copper signifi-
cantly increased mitochondrial outer membrane damage in a
concentration-dependent manner for the Cu 20 mg kg1 group
(P o 0.05) compared to the control group and for the Cu
200 mg kg1 + Ab group (Po 0.05) compared to the Ab treated
group (Fig. 5B).
3.2.5. Mitochondrial lipid peroxidation. The results show
that lipid peroxidation (MDA formation) was increased by
copper in a concentration dependent manner in the isolated
hippocampal mitochondria. The amounts of MDA formation in
the hippocampal mitochondria were 6.76  1.2, 9  1.2 and
9.2  1.3 mg MDA per mg protein at 50, 100 and 200 mg kg1
copper concentration, respectively, whereas that of the control
group was 5.47  0.9 mg MDA mg1 protein. The MDA levels
also increased to 10.02  1, 10.6  1.1, 13.3  1.4 and 13.63 
1.4 (mg mg1 protein) by Ab, Cu 50mg kg1 + Ab, Cu 100 mg kg1 +
Ab and Cu 200 mg kg1 + Ab, respectively (Fig. 6A).
3.2.6. Mitochondrial glutathione content. Glutathione is a
main antioxidant defense factor against various ROS, such as
H2O2. GSH through a non-enzymatic reaction can directly react
with H2O2 and is oxidized to GSSG.
46 Consequent to the observation
of copper eﬀect on H2O2 generation and lipid peroxidation, its
possible eﬀect on the antioxidant systems was also determined. The
GSH concentration in the brain mitochondria was evaluated to
determine the extent of oxidative stress induced by Cu. As shown in
Fig. 6B, copper significantly decreased the GSH levels in a dose
dependent manner. At 50, 100 and 200 mg kg1 Cu concentrations,
the GSH levels decreased to 26.13  2.04, 21.17  2.16 and 17.97 
2.45 (mgmg1 protein), respectively, and for the control group it was
28.27  1.9 mg mg1 protein. The GSH levels also decreased to
15.7  2, 14.73  2.6, 10.77  2.2 and 9.5  2.8 mg mg1 protein
by Ab, Cu 50 mg kg1 + Ab, Cu 100 mg kg1 + Ab and Cu
200 mg kg1 + Ab, respectively (Fig. 6B).
3.2.7. Mitochondrial ADP/ATP ratios. Mitochondrial
respiratory processes are required for ATP production in
Fig. 5 A plot of the eﬀect of the control, copper doses, Ab and copper
doses + Ab groups on cytochrome c oxidase activity (A) and mitochondrial
outer membrane damage (B). *P o 0.05, **P o 0.01, ***P o 0.001 and
****P o 0.0001 compared to control group. #P o 0.05 and ##P o 0.01
compared to Ab-injected group. The values represent means  SD (n = 7).
Fig. 6 A plot of the eﬀect of the control, copper doses, Ab and copper
doses + Ab groups on lipid peroxidation (A) and GSH content (B).
*P o 0.05, **P o 0.01, ***P o 0.001 and ****P o 0.0001 compared to
control group. #P o 0.05 and ##P o 0.01 compared to Ab-injected
group. The values represent means  SD (n = 7).
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mitochondria, since copper impaired themitochondrial respiration;
therefore, wemeasured the ADP/ATP ratios in isolated hippocampal
mitochondria. As shown in Fig. 7, there was a statistically significant
increase in the ADP/ATP ratios in the Cu 100 and 200 mg kg1
groups (P o 0.05) compared to the control group. Furthermore, a
significant increase in the ADP/ATP ratio in the Cu 100 mg kg1 +
Ab (Po 0.05) and Cu 200mg kg1 + Ab groups (Po 0.01) compared
to the Ab treated group was observed (Fig. 7).
3.3. Brain hippocampal copper concentrations
The increase in hippocampal Cu concentrations was proportional
to the dose of exposure. The Cu concentrations in the hippocampi
of the rats were significantly higher in the groups receiving copper
100 mg kg1 and 100 mg kg1 + Ab (P o 0.01) and also in the
groups receiving Cu 200 mg kg1 and 200 mg kg1 + Ab (P o
0.001) compared to the control group (Table 1).
4. Discussion
The results of this study show that chronic copper sulfate
administration (for 3 weeks) in the drinking water markedly
induced learning and memory impairment. Sole copper sulfate
administration in rats induced oxidative damage in the
hippocampal mitochondria. In co-administration with amyloid
beta, copper sulfate could potentiate Ab induced learning and
memory impairment and mitochondrial dysfunction in a
concentration dependent manner. Squitti et al.47 studied the
amount of serum copper in 79 Alzheimer’s disease patients
(54 women and 25 men; mean age 74.3 years) and in 76 individuals
with normal cognitive function (43 women and 33 men; mean
age 70.1 years). Their studies showed that the copper content
was significantly higher in AD patients compared to the control
groups and also an increase of 1 mmol L1 in the serum copper
level could elevate the risk of having AD by about 80% and has a
close relationship with poor neuropsychological performance
and atrophy of the medial temporal lobe. To the best of our
knowledge, this is the first study that reports the eﬀects of
copper alone and with amyloid beta on spatial memory and
mitochondrial impairments. This finding supports previous
research, which found accumulation of amyloid beta peptides
and memory deficit caused by copper neurotoxicity. Sparks et al.48
reported that adding 0.12 PPM copper sulfate (0.75 mM) for
ten weeks to the drinking water of cholesterol-fed beagles,
spontaneously hypercholesterolemic Watanabe rabbits and
PS1/APP transgenic mice generated significantly elevated brain
levels of Ab. Becaria et al.49 also showed that 3 months’ exposure
of mice to copper sulfate (8 mM) in the drinking water initiated
oxidative and inflammatory events in the brain and that it may
function to enhance APP levels with aluminum co-exposure.
Ceccom et al.50 reported the capacity of a new copper-specific
chelating agent, a bis-8-aminoquinoline PA1637, to entirely
reverse the deficit of episodic memory after 21 days of treatment
by the oral route on non-transgenic amyloid-impaired mice.
Kumar et al.51 declared that all behavioral tests (percentage
attention score in Y-maze, maximum peak force in grip strength
and latency to fall in rotarod) were significantly decreased in
rats that received oral copper sulfate in doses of 100 and
200 mg kg1 (especially in the 200 mg kg1 group) at all time
points (30 days, 60 days and 90 days of exposure) compared to
the control group. However, the findings of our study diﬀer
from the study by Leiva et al.52 which suggests no diﬀerence
between the copper-treated and control groups in the training
days of MWM. A possible explanation for this diﬀerence might
be the lower dose of Cu in this study compared to our study. In
the study by Leiva et al.,52 CuSO4 dissolved in saline was injected
(ip) 1 mg kg1 for 30 days and then MWMwas performed. Singh
et al.53 elucidated the mechanism of Cu-induced Ab accumulation
in the brains of mice and their studies showed that in aging mice,
accumulation of Cu in the brain capillaries was associated with
its decrease in low-density lipoprotein receptor-related protein
1 (LRP1), an Ab transporter, and excess brain Ab levels. These
eﬀects were reproduced by chronic dosing with low levels of Cu
through drinking water and they also reported that Cu not only
down-regulated LRP1 in the brain capillaries but also increased
Ab generation and neuroinflammation. One of the possible
mechanisms of copper induced neurotoxicity in various brain
systems is mitochondrial function impairment, which has not
been studied in any of the previous studies in relation to
learning and memory deficit.
Fig. 7 A plot of the eﬀect of the control, copper doses, Ab and copper doses +
Ab groups on hippocampus ADP/ATP ratios. *P o 0.05, **P o 0.01, ***P o
0.001 and ****Po 0.0001 compared to control group. #Po 0.05 and ##Po
0.01 compared to Ab-injected group. The values represent means SD (n = 7).
Table 1 Brain hippocampal copper concentrations after 3 weeks’ exposure
to diﬀerent doses of Cu in the drinking water
Groups
Hippocampal copper concentration
(mg g1 wet weight)
Control 0.19  0.02
Cu 50 mg kg1 0.21  0.03
Cu 100 mg kg1 0.25  0.03**
Cu 200 mg kg1 0.27  0.04***
Ab 1 mg ml1 per side 0.2  0.03
Ab + Cu 50 mg kg1 0.22  0.02
Ab + Cu 100 mg kg1 0.26  0.04**
Ab + Cu 200 mg kg1 0.27  0.03***
The copper concentration was determined by atomic absorption spectro-
photometry as described in thematerials andmethods. **Po 0.01, ***Po
0.001 compared with the control group. The values represent means  SD
for seven rats in each group.
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It has been known that in copper overload disorders, the
mitochondrion is the main target of toxicity, which is associated
withmitochondrial ETC dysfunction and oxidative stress-mediated
reduction of the mitochondrial membrane potential (Cm), mito-
chondrial membrane integrity and ATP production.54
The results of this study demonstrate that Cu in high
concentrations could increase and potentiate (in Ab treated
animals) ROS generation in hippocampal mitochondria and
cause memory disorder. This finding is in agreement with the
findings of White et al.,55 which showed that in primary mouse
neuronal cultures, homocysteine, a thiol-containing amino
acid, in the presence of micromolar concentrations of Cu(II)
produced high levels of hydrogen peroxide and promoted Ab/
Cu-mediated hydrogen peroxide generation and neurotoxicity.
They also suggested that high levels of copper and/or
homocysteine in the elderly could promote serious oxidative
damage to neurons and may indicate additional risk factor
pathways which conspire to generate AD or related neurode-
generative diseases. Changing or inhibiting the activity of
mitochondrial complexes leads to MMP disruption, which
aﬀects the generation rate of ATP via complex V. This study
indicates that following Cu administration, MMP was reduced
in a dose dependant manner and also, in elevated concentrations,
Cu could exacerbate MMP reduction in the Ab treated groups.
Ozcelik et al.5 reported that Cu overload in the brain reduced SOD
activities and GSH levels and also increased MDA levels due to
lipid peroxidation. Glutathione (GSH) is one of the main non-
enzymatic antioxidant systems against hydrogen peroxide and
other ROS, which constitutes almost 10–15% of total cellular
GSH in mitochondria.56 Therefore, the decrease of reduced
glutathione content in mitochondria could cause severe weak-
ness in their defense system against oxidative damage and a
further rise in lipid peroxidation. As our data show, copper in a
dose dependent manner induced and exacerbated (in Ab-injected
rats) the GSH oxidation and lipid peroxidation in exposed
hippocampal mitochondria. Moreover, GSH is required for the
maintenance of thiol groups in mitochondrial membrane proteins
in the reduced form.43 When these thiol groups are oxidized,
conformational changes arise in the pore complex that lead to
mitochondrial permeability transition (MPT).57 Thus, Cu-induced
ROS production not only leads to GSH oxidation and lipid
peroxidation, it could also destroy the mitochondrial membrane
integrity and open the MPT pores. The opening of MPT pores
initiates the onset of apoptosis and necrosis mechanisms.58
Mitochondrial swelling is a structural change of isolated mito-
chondria undergoing permeability transition.59 Several agents
such as oxidants, heavy metals and sulfhydryl reactive compounds
are capable of inducing the permeability transition.59 In this study,
copper in a dose dependent manner was found to cause and
worsen (in Ab-injected rats) mitochondrial swelling in the brain
hippocampus. It is possible that mitochondrial swelling occurs
due to the destruction of mitochondrial membrane integrity
resulting from elevated ROS production, which causes the collapse
of MMP. The present finding seems to be consistent with other
research, which showed copper induced mitochondrial swelling
in vitro.60 This study shows that copper in a dose dependent
manner significantly increased and deteriorated (in Ab-injected
rats) the outer membrane damage. As a result, Cu-induced lipid
oxidation in hippocampal mitochondria (as a consequence of
respiratory chain impairment and a decrease in GSH) could promote
mitochondrial membrane destruction and finally the lack of mito-
chondrial outer membrane integrity. Mitochondria are essential for
cell survival due to their roles as moderators of apoptosis.61 Pro-
grammed cell death may occur when the amount of ROS produced
in the mitochondria cannot be neutralized by the radical-scavenging
cellular antioxidants. The mechanism of ROS-mediated apoptosis
illustrates the involvement of the MPT pore opening and release of
cytochrome c from mitochondria and their ATP-dependent inter-
action with cytosolic factors for the formation of apoptosome in
order to activate caspase-9 and caspase-3, respectively.62
Crouch et al.63 indicated that Ab 1–42, in its dimeric con-
formation is associated with brain mitochondrial function and
the presence of Cu2+ is a potent inhibitor of cytochrome c oxidase
(COX) activity in a dose-dependent manner. They concluded that
inhibition of COX activity by Cu2+-dependent Ab may be a main
contributor to the neurodegenerative process in Alzheimer’s disease.
We also investigated the effect of copper on the activity of complex
IV (cytochrome c oxidase) of the mitochondrial electron transfer
chain. As shown in the results, copper in a concentration dependent
manner significantly decreased cytochrome c oxidase activity in the
mitochondria of brain hippocampi and also could exacerbate the
reduced activity of cytochrome c oxidase in Ab-injected rats.
The most important mitochondrial function is ATP production
through oxidative phosphorylation. Furthermore, the ATP level
defines the process of cell death in target cells.64 In fact, ATP acts
as a switch between apoptosis and necrosis. Apoptosis requires
ATP, while depletion of ATP shift cells to necrosis and interrupts
apoptosis.64 We found that copper in a concentration dependent
manner decreased ATP production and increased the ADP/ATP
ratio in isolated hippocampal mitochondria and could also inten-
sify the increased ADP/ATP ratio in Ab treated rats. This might be
due to the inhibition of the mitochondrial respiratory chain and
MPT pore opening. Pereira et al.65 reported that inhibition of the
mitochondrial ETC could lead to a reduction in MMP and ATP
production. In fact, when theMPT pore opened, unlimited protons
moved across the inner membrane and subsequently resulted in
the uncoupling of oxidative phosphorylation.61 The remaining ATP
was consumed immediately for MMP maintenance, resulting in a
further decrease in the ATP level; this leads to exacerbation of ROS
generation.61 Hosseini et al.60 suggested that mitochondrial toxi-
city of Cu2+ on isolated rat liver could lead to increased disturbance
in oxidative phosphorylation and a decreased ATP/ADP ratio. They
also showed that Cu2+ induced liver toxicity in a concentration and
time-dependent manner because of its eﬀects on liver hepatocyte
mitochondria through lipid peroxidation, ROS formation, release
of cytochrome c and mitochondrial membrane potential reduction,
which start cell death signalling.
5. Conclusion
The results of this study show that chronic copper (for 3 weeks)
in drinking water results in increased ROS formation followed
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by MMP collapse, increased ADP/ATP ratio, mitochondrial outer
membrane damage, mitochondrial swelling and finally decreased
cytochrome c oxidase activity in a concentration dependent
manner. Given the key role of mitochondria in synaptic plasticity
as the important component in learning and memory formation,
the copper-induced dysfunction of neuronal mitochondria could be
considered as the mechanism of copper-induced spatial learning
and memory impairments in rats. Copper also could exacerbate the
destructive eﬀects of amyloid beta on brain hippocampal mito-
chondria and spatial memory in Ab-injected rats.
Abbreviations
MWM Morris water maze test
Ab Beta-amyloid peptide 1–42
ROS Reactive oxygen species
MMP Mitochondrial membrane potential
IH Intrahippocampally.
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